Fanconi anemia surgery: Difference between revisions
Jump to navigation
Jump to search
Sunny Kumar (talk | contribs) No edit summary |
Shyam Patel (talk | contribs) No edit summary |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 2: | Line 2: | ||
{{Fanconi anemia}} | {{Fanconi anemia}} | ||
{{CMG}}; {{AE}} {{shyam}} | |||
== Overview == | == Overview == | ||
There is no surgical treatment of | There is no surgical treatment of Fanconi anemia. | ||
== Surgery == | == Surgery == | ||
There is no surgical treatment of | There is no surgical treatment of Fanconi anemia. However elective splenectomy and [[bone marrow transplant]] are end-stage therapies for Fanconi anemia, as is true for any other aplastic anemia.<ref name="pmid29907598">{{cite journal| author=Guan J, Fransson S, Siaw JTT, Treis D, Van den Eynden J, Chand D et al.| title=Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib. | journal=Cold Spring Harb Mol Case Stud | year= 2018 | volume= | issue= | pages= | pmid=29907598 | doi=10.1101/mcs.a002550 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29907598 }}</ref><ref name="pmid29901137">{{cite journal| author=Kulanuwat S, Jungtrakoon P, Tangjittipokin W, Yenchitsomanus PT, Plengvidhya N| title=Fanconi anemia complementation group C protection against oxidative stress‑induced β‑cell apoptosis. | journal=Mol Med Rep | year= 2018 | volume= | issue= | pages= | pmid=29901137 | doi=10.3892/mmr.2018.9163 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29901137 }}</ref><ref name="pmid29719599">{{cite journal| author=Verhagen CVM, Vossen DM, Borgmann K, Hageman F, Grénman R, Verwijs-Janssen M et al.| title=Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma. | journal=Oncotarget | year= 2018 | volume= 9 | issue= 26 | pages= 18198-18213 | pmid=29719599 | doi=10.18632/oncotarget.24797 | pmc=5915066 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29719599 }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 05:03, 4 May 2019
|
Fanconi anemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fanconi anemia surgery On the Web |
|
American Roentgen Ray Society Images of Fanconi anemia surgery |
|
Risk calculators and risk factors for Fanconi anemia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shyam Patel [2]
Overview
There is no surgical treatment of Fanconi anemia.
Surgery
There is no surgical treatment of Fanconi anemia. However elective splenectomy and bone marrow transplant are end-stage therapies for Fanconi anemia, as is true for any other aplastic anemia.[1][2][3]
References
- ↑ Guan J, Fransson S, Siaw JTT, Treis D, Van den Eynden J, Chand D; et al. (2018). "Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib". Cold Spring Harb Mol Case Stud. doi:10.1101/mcs.a002550. PMID 29907598.
- ↑ Kulanuwat S, Jungtrakoon P, Tangjittipokin W, Yenchitsomanus PT, Plengvidhya N (2018). "Fanconi anemia complementation group C protection against oxidative stress‑induced β‑cell apoptosis". Mol Med Rep. doi:10.3892/mmr.2018.9163. PMID 29901137.
- ↑ Verhagen CVM, Vossen DM, Borgmann K, Hageman F, Grénman R, Verwijs-Janssen M; et al. (2018). "Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma". Oncotarget. 9 (26): 18198–18213. doi:10.18632/oncotarget.24797. PMC 5915066. PMID 29719599.